Erika Morris joined Scorpius BioManufacturing in May 2024 as a Director of Business Development, where she oversees the Midwest region. She brings 20+ years of scientific and biopharma business development experience to Scorpius, having most recently been the Director of Business Intelligence and Business Development at Ajinomoto Bio-Pharma Services. She has additional CDMO experience as a Senior Business Development Manager at Singota. Her hands-on scientific background as a QC Method Transfer Associate, Staff Scientist, and Biochemist makes her an expert at assisting Scorpius clients with complex biomanufacturing and bioanalytical programs. Erika earned a B.S. in Biochemistry and an M.S. in Biochemistry from Purdue University.
Kyle Lauterbach is Associate Director of Proposals at Scorpius Biomanufacturing. He has over 20 years of experience in the bioprocessing industry including large biopharma, biopharma CDMOs, and biofuels start-ups. Kyle spent over a decade in late-stage fermentation and cell culture process development at Amgen where he conducted process characterization and commercial manufacturing support for multiple GMP programs. He then transitioned into business roles in project management at Algenol and proposal development at KBI Biopharma.
Kyle joined Scorpius BioManufacturing in 2024 where he is responsible for managing the scoping, pricing, and scheduling of client proposals. He holds a BS in biology from Emory University and an MBA in Entrepreneurship from the University of Colorado at Boulder.
Nicole is Head of Program Management at Scorpius, where she ensures the successful delivery of client projects while maintaining high standards of quality, compliance, and customer satisfaction. She is an accomplished leader with nearly 15 years of biopharma experience and a passion for driving strategic initiatives and managing complex programs to successful outcomes.
Before joining Scorpius, Nicole held various leadership roles where she consistently demonstrated her ability to inspire teams and foster a culture of collaboration and innovation. Her expertise lies in optimizing processes, mitigating risks, and maximizing resource efficiency, all while maintaining a focus on quality and excellence. She holds a B.S. in Biology and Healthcare-Business from University of Wisconsin-Oshkosh and actively pursues opportunities for professional growth and development. Recognized for her analytical acumen, effective communication skills, and unwavering commitment to success, Nicole is dedicated to driving organizational excellence through strategic program management.
Erika Morris joined Scorpius BioManufacturing in May 2024 as a Director of Business Development, where she oversees the Midwest region. She brings 20+ years of scientific and biopharma business development experience to Scorpius, having most recently been the Director of Business Intelligence and Business Development at Ajinomoto Bio-Pharma Services. She has additional CDMO experience as a Senior Business Development Manager at Singota. Her hands-on scientific background as a QC Method Transfer Associate, Staff Scientist, and Biochemist makes her an expert at assisting Scorpius clients with complex biomanufacturing and bioanalytical programs. Erika earned a B.S. in Biochemistry and an M.S. in Biochemistry from Purdue University.
Kyle Lauterbach is Associate Director of Proposals at Scorpius Biomanufacturing. He has over 20 years of experience in the bioprocessing industry including large biopharma, biopharma CDMOs, and biofuels start-ups. Kyle spent over a decade in late-stage fermentation and cell culture process development at Amgen where he conducted process characterization and commercial manufacturing support for multiple GMP programs. He then transitioned into business roles in project management at Algenol and proposal development at KBI Biopharma.
Kyle joined Scorpius BioManufacturing in 2024 where he is responsible for managing the scoping, pricing, and scheduling of client proposals. He holds a BS in biology from Emory University and an MBA in Entrepreneurship from the University of Colorado at Boulder.
Nicole is Head of Program Management at Scorpius, where she ensures the successful delivery of client projects while maintaining high standards of quality, compliance, and customer satisfaction. She is an accomplished leader with nearly 15 years of biopharma experience and a passion for driving strategic initiatives and managing complex programs to successful outcomes.
Before joining Scorpius, Nicole held various leadership roles where she consistently demonstrated her ability to inspire teams and foster a culture of collaboration and innovation. Her expertise lies in optimizing processes, mitigating risks, and maximizing resource efficiency, all while maintaining a focus on quality and excellence. She holds a B.S. in Biology and Healthcare-Business from University of Wisconsin-Oshkosh and actively pursues opportunities for professional growth and development. Recognized for her analytical acumen, effective communication skills, and unwavering commitment to success, Nicole is dedicated to driving organizational excellence through strategic program management.
Phillip Schneider joined Scorpius BioManufacturing in May 2024, bringing expertise in proposal development and CDMO commercial operations. As a Proposal Lead at Catalent Pharma Solutions, Phillip utilized problem-solving and strategy skills to generate and deliver winning proposals for clients in the pharmaceutical and biotechnology industries. Phillip holds a B.A. in Medicine and International Relations and a M.S. in Biotechnology from the University of Wisconsin-Madison.
Janet Holmes is a Proposal Writer at Scorpius BioManufacturing. She has 20+ years of experience in the bioprocessing industry, including large biopharma (Pfizer, Genzyme), biopharma CDMOs (Batavia Biosciences, Vibalogics, Lonza), and emerging biotechs (Intellia Therapeutics, PCT Therapeutics, Atara Biotherapeutics, Denali Therapeutics). Janet’s writing and documentation experience includes proposals, regulatory submissions, quality documents, process reports, and SOPs. In addition to her writing background, Janet was a senior scientist working on cell culture process development and a process engineer/analytical scientist. She has worked on a wide range of biotherapeutics, including recombinant antibodies, virus-like particles, vaccines, biosimilars, and gene therapies. Her strong technical background – coupled with her scientific writing proficiency – allows her to guide Scorpius’ partners on the best path for the clinical drug substance manufacturing needs.
Janet joined Scorpius in 2024 to develop the scope, pricing, and timeline of proposals for both new and ongoing biologics programs. She holds a BS from the University of Massachusetts and an MA from Salem State College. When she is not writing proposals, Janet is a certified hypnotist and licensed pilot.
Phillip Schneider joined Scorpius BioManufacturing in May 2024, bringing expertise in proposal development and CDMO commercial operations. As a Proposal Lead at Catalent Pharma Solutions, Phillip utilized problem-solving and strategy skills to generate and deliver winning proposals for clients in the pharmaceutical and biotechnology industries. Phillip holds a B.A. in Medicine and International Relations and a M.S. in Biotechnology from the University of Wisconsin-Madison.
Janet Holmes is a Proposal Writer at Scorpius BioManufacturing. She has 20+ years of experience in the bioprocessing industry, including large biopharma (Pfizer, Genzyme), biopharma CDMOs (Batavia Biosciences, Vibalogics, Lonza), and emerging biotechs (Intellia Therapeutics, PCT Therapeutics, Atara Biotherapeutics, Denali Therapeutics). Janet’s writing and documentation experience includes proposals, regulatory submissions, quality documents, process reports, and SOPs. In addition to her writing background, Janet was a senior scientist working on cell culture process development and a process engineer/analytical scientist. She has worked on a wide range of biotherapeutics, including recombinant antibodies, virus-like particles, vaccines, biosimilars, and gene therapies. Her strong technical background – coupled with her scientific writing proficiency – allows her to guide Scorpius’ partners on the best path for the clinical drug substance manufacturing needs.
Janet joined Scorpius in 2024 to develop the scope, pricing, and timeline of proposals for both new and ongoing biologics programs. She holds a BS from the University of Massachusetts and an MA from Salem State College. When she is not writing proposals, Janet is a certified hypnotist and licensed pilot.